Contineum Therapeutics (CTNM) News Today $11.35 +0.60 (+5.58%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$11.08 -0.28 (-2.42%) As of 10/3/2025 04:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CTNM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Contineum Therapeutics, Inc. (NASDAQ:CTNM) Receives $22.20 Average PT from AnalystsOctober 1, 2025 | americanbankingnews.comHere's Why We're Not Too Worried About Contineum Therapeutics' (NASDAQ:CTNM) Cash Burn SituationSeptember 30, 2025 | finance.yahoo.comBrokers Set Expectations for CTNM Q3 EarningsSeptember 30, 2025 | americanbankingnews.comWhat is Leerink Partnrs' Estimate for CTNM Q3 Earnings?September 29, 2025 | marketbeat.comContineum Therapeutics, Inc. (NASDAQ:CTNM) Receives Average Recommendation of "Buy" from BrokeragesSeptember 28, 2025 | marketbeat.comContineum Therapeutics (NASDAQ:CTNM) Coverage Initiated by Analysts at Leerink PartnersSeptember 27, 2025 | americanbankingnews.comContineum Therapeutics (NASDAQ:CTNM) Upgraded to Strong-Buy at Leerink PartnrsSeptember 26, 2025 | marketbeat.comLeerink Partners Initiates Coverage of Contineum Therapeutics (CTNM) with Outperform RecommendationSeptember 25, 2025 | msn.comContineum Therapeutics (NASDAQ:CTNM) Coverage Initiated at Leerink PartnersSeptember 25, 2025 | marketbeat.comBuy Rating for Contineum Therapeutics Driven by Strategic Positioning and Enhanced Efficacy in IPF MarketSeptember 25, 2025 | tipranks.comPromising Potential of PIPE-791: Buy Rating for Contineum Therapeutics Amid Positive Phase 1b ResultsSeptember 19, 2025 | tipranks.comContineum Therapeutics Reports Positive Topline Data From Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791September 18, 2025 | businesswire.comContineum Therapeutics, Inc. (NASDAQ:CTNM) Short Interest UpdateSeptember 17, 2025 | marketbeat.comContineum Therapeutics, Inc. (NASDAQ:CTNM) Short Interest Up 63.5% in AugustSeptember 8, 2025 | marketbeat.comADAR1 Capital Management LLC Has $1.18 Million Holdings in Contineum Therapeutics, Inc. $CTNMSeptember 4, 2025 | marketbeat.comContineum Therapeutics, Inc. (NASDAQ:CTNM) Receives Average Rating of "Buy" from AnalystsSeptember 4, 2025 | marketbeat.comContineum Therapeutics to Present at September Investor ConferencesAugust 28, 2025 | businesswire.comPositive week for Contineum Therapeutics, Inc. (NASDAQ:CTNM) institutional investors who lost 47% over the past yearAugust 20, 2025 | finance.yahoo.comContineum Therapeutics (NASDAQ:CTNM) Stock Price Expected to Rise, Morgan Stanley Analyst SaysAugust 20, 2025 | marketbeat.comAnalysts Offer Insights on NA Companies: Contineum Therapeutics, Inc. Class A (CTNM) and BrightSpring Health Services, Inc. (BTSG)August 17, 2025 | theglobeandmail.comContineum Therapeutics Reports Q2 2025 Results and Clinical ProgressAugust 13, 2025 | tipranks.comContineum Therapeutics (NASDAQ:CTNM) Shares Down 3.9% - Time to Sell?August 10, 2025 | marketbeat.comContineum Therapeutics, Inc. (NASDAQ:CTNM) Given Consensus Recommendation of "Buy" by BrokeragesAugust 10, 2025 | marketbeat.comWilliam Blair Has Bullish Forecast for CTNM Q3 EarningsAugust 9, 2025 | marketbeat.comContineum Therapeutics (NASDAQ:CTNM) Issues Earnings Results, Misses Expectations By $0.06 EPSAugust 6, 2025 | marketbeat.comContineum Therapeutics (CTNM) Projected to Post Quarterly Earnings on TuesdayAugust 6, 2025 | marketbeat.comContineum (CTNM) Q2 R&D Jumps 78%August 5, 2025 | fool.comContineum Therapeutics Reports Second-Quarter 2025 Financial Results; Updates Key Clinical Development MilestonesAugust 5, 2025 | businesswire.comContineum Therapeutics Inc. (CTNM) Stock Price Today - WSJAugust 1, 2025 | wsj.comContineum Therapeutics, Inc. (NASDAQ:CTNM) Receives Average Recommendation of "Buy" from AnalystsJuly 15, 2025 | marketbeat.comContineum Therapeutics (NASDAQ:CTNM) Shares Down 2.7% - What's Next?July 12, 2025 | marketbeat.comContineum Therapeutics stock falls after trial data delayJune 25, 2025 | investing.comContineum Therapeutics Shares Drop After Delay in Trial Data ReleaseJune 25, 2025 | msn.comContineum Therapeutics Provides Update on Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791June 25, 2025 | businesswire.comContineum Therapeutics (NASDAQ:CTNM) Coverage Initiated at William BlairJune 20, 2025 | marketbeat.comContineum Therapeutics, Inc. (NASDAQ:CTNM) Receives Consensus Rating of "Buy" from AnalystsJune 20, 2025 | marketbeat.comSquarepoint Ops LLC Trims Position in Contineum Therapeutics, Inc. (NASDAQ:CTNM)May 28, 2025 | marketbeat.comPolar Capital Holdings Plc Reduces Stock Position in Contineum Therapeutics, Inc. (NASDAQ:CTNM)May 19, 2025 | marketbeat.comContineum Therapeutics to Present at the 2025 RBC Capital Markets Global Healthcare ConferenceMay 15, 2025 | businesswire.comContineum Therapeutics Reports Q1 2025 Financial ResultsMay 14, 2025 | tipranks.comContineum Therapeutics Reports First-Quarter 2025 Financial Results; Affirms Key Clinical Development MilestonesMay 14, 2025 | businesswire.comContineum Therapeutics (CTNM) Expected to Announce Earnings on ThursdayMay 10, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Buys Shares of 125,995 Contineum Therapeutics, Inc. (NASDAQ:CTNM)May 8, 2025 | marketbeat.comGeode Capital Management LLC Purchases 59,732 Shares of Contineum Therapeutics, Inc. (NASDAQ:CTNM)April 30, 2025 | marketbeat.comContineum Therapeutics Appoints Timothy Watkins, M.D., M.Sc., as Chief Medical Officer and Head of DevelopmentApril 30, 2025 | finance.yahoo.comWe're Not Very Worried About Contineum Therapeutics' (NASDAQ:CTNM) Cash Burn RateApril 23, 2025 | finance.yahoo.comNorges Bank Acquires Shares of 169,729 Contineum Therapeutics, Inc. (NASDAQ:CTNM)April 14, 2025 | marketbeat.comContineum Therapeutics Rings the Nasdaq Stock Market Closing BellApril 10, 2025 | nasdaq.comContineum Therapeutics Rings the Closing BellApril 10, 2025 | nasdaq.comADAR1 Capital Management LLC Raises Stock Position in Contineum Therapeutics, Inc. (NASDAQ:CTNM)April 9, 2025 | marketbeat.com Get Contineum Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CTNM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CTNM Media Mentions By Week CTNM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CTNM News Sentiment▼0.430.54▲Average Medical News Sentiment CTNM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CTNM Articles This Week▼42▲CTNM Articles Average Week Get the Latest News and Ratings for CTNM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Contineum Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies XERS News Today LENZ News Today PHVS News Today EVO News Today STOK News Today ZYME News Today SION News Today NUVB News Today AMPH News Today AMLX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CTNM) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Contineum Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Contineum Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTNM Stock Alerts